1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Amyloid blood biomarker detects Alzheimer's disease
- Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
- CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
- Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
- 2017
- CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
- Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
- Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
- Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
- Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
- Concordance between different amyloid immunoassays and Visual amyloid positron emission tomographic assessment